Ad is loading...
FJPTX
Price
$16.93
Change
-$0.15 (-0.88%)
Updated
Nov 15 closing price
RMBPX
Price
$10.25
Change
-$0.11 (-1.06%)
Updated
Nov 15 closing price
Ad is loading...

FJPTX vs RMBPX

Header iconFJPTX vs RMBPX Comparison
Open Charts FJPTX vs RMBPXBanner chart's image
Fidelity Advisor Japan M
Price$16.93
Change-$0.15 (-0.88%)
VolumeN/A
CapitalizationN/A
RMB Japan I
Price$10.25
Change-$0.11 (-1.06%)
VolumeN/A
CapitalizationN/A
FJPTX vs RMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FJPTX vs. RMBPX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FJPTX is a Buy and RMBPX is a Sell.

FUNDAMENTALS
Fundamentals
FJPTX has more cash in the bank: 693M vs. RMBPX (21.7M). RMBPX pays higher dividends than FJPTX: RMBPX (4.01) vs FJPTX (0.20). FJPTX was incepted earlier than RMBPX: FJPTX (14 years) vs RMBPX (7 years). RMBPX is a more actively managed with annual turnover of: 52.00 vs. FJPTX (25.00). FJPTX has a lower initial minimum investment than RMBPX: FJPTX (0) vs RMBPX (100000). FJPTX (11.12) and RMBPX (10.86) have marching annual gain over last year. RMBPX return over 5 years is better than : 12.03 vs. FJPTX (8.37).
FJPTXRMBPXFJPTX / RMBPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years7 years-
Gain YTD6.6794.592145%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets693M21.7M3,194%
Annual Yield % from dividends0.204.015%
Returns for 1 year11.1210.86102%
Returns for 3 years-19.50-3.41572%
Returns for 5 years8.3712.0370%
Returns for 10 years50.50N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV12.740.11
+0.87%
XPeng
XOM119.31-1.25
-1.04%
Exxon Mobil Corp
LDTC0.32-0.01
-1.76%
LeddarTech Holdings
MYGN15.25-0.43
-2.74%
Myriad Genetics
URGN11.19-0.67
-5.65%
UroGen Pharma Ltd